Two new RCTs of rituximab will soon begin in the United Kingdom: A biomarker-based trial with add-on belimumab and another in ...

A global survey conducted by the World Lupus Federation reveals that 47% of people living with lupus report kidney ...

Lupus presents unique challenges, particularly for patients with lupus nephritis — a severe form of the condition that affects kidney function and quality of life. Current treatments often come with ...

LIVEKIDNEY.BIO (LiveKidney), a clinical-stage biotech company developing cell-based therapies for kidney diseases, announced today that it has enrolled its first patient in a Phase I/IIa study of ...

Investigators assessed the frequency of lupus flares in patients with kidney failure undergoing dialysis or with a kidney transplant.

At univariable analysis, both anti-C1q antibodies and non-use of hydroxychloroquine predicted renal flares at baseline and 6 and 12 months. Proteinuria (24/h proteinuria and proteinuria 0.5 g/day or ...

An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

The cell and gene therapy company is cutting 47 employees and its entire lupus program to focus resources on two CAR Ts. The ...